Literature DB >> 18787184

Involvement of native TRPC3 proteins in ATP-dependent expression of VCAM-1 and monocyte adherence in coronary artery endothelial cells.

Kathryn Smedlund1, Guillermo Vazquez.   

Abstract

UNLABELLED: Background- Vascular cell adhesion molecule-1 (VCAM-1) is critical in monocyte recruitment to the endothelium, a key event in development of atherosclerotic lesions. Stimulation of human coronary artery endothelial cells (HCAECs) with ATP positively modulates VCAM-1 expression and function through a mechanism involving Ca(2+) signaling. We here examined the role of Ca(2+) influx and native TRPC3 channels in that mechanism. METHODS AND
RESULTS: Omission of extracellular Ca(2+) or pretreatment of cells with channel blockers markedly reduced ATP-induced VCAM-1 and monocyte adhesion. Using a siRNA strategy and real-time fluorescence, we found that native TRPC3 proteins contribute to constitutive and ATP-regulated Ca(2+) influx. ATP-dependent upregulation of VCAM-1 was accompanied by an increase in basal cation entry and TRPC3 expression. Notably, TRPC3 knock-down resulted in a dramatic reduction of ATP-induced VCAM-1 and monocyte adhesion.
CONCLUSIONS: These findings indicate that in HCAECs, native TRPC3 proteins form channels that contribute to constitutive and ATP-dependent Ca(2+) influx, and that TRPC3 expression and function are fundamental to support VCAM-1 expression and monocyte binding. This is the first evidence to date relating native TRPC3 proteins with regulated expression of cell adhesion molecules in coronary endothelium, and suggests a potential pathophysiological role of TRPC3 in coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787184     DOI: 10.1161/ATVBAHA.108.175356

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  19 in total

1.  Increased size and cellularity of advanced atherosclerotic lesions in mice with endothelial overexpression of the human TRPC3 channel.

Authors:  Kathryn B Smedlund; Lutz Birnbaumer; Guillermo Vazquez
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

Review 2.  Canonical transient receptor potential channels in diabetes.

Authors:  Sarabeth Graham; Joseph P Yuan; Rong Ma
Journal:  Exp Biol Med (Maywood)       Date:  2012-01-26

Review 3.  Transient Receptor Potential Channels and Endothelial Cell Calcium Signaling.

Authors:  Pratish Thakore; Scott Earley
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

Review 4.  Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability.

Authors:  Yulia A Komarova; Kevin Kruse; Dolly Mehta; Asrar B Malik
Journal:  Circ Res       Date:  2017-01-06       Impact factor: 17.367

5.  A Selective TRPC3 Inhibitor Pyr3 Attenuates Myocardial Ischemia/Reperfusion Injury in Mice.

Authors:  Min Lu; Xiao-Xia Fang; Dan-Dan Shi; Rui Liu; Yan Ding; Qiu-Fang Zhang; Han-Qin Wang; Jun-Ming Tang; Xi-Ju He
Journal:  Curr Med Sci       Date:  2021-01-11

Review 6.  On the role of endothelial TRPC3 channels in endothelial dysfunction and cardiovascular disease.

Authors:  K Smedlund; M Bah; G Vazquez
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2012-09

7.  Update on vascular endothelial Ca(2+) signalling: A tale of ion channels, pumps and transporters.

Authors:  Francesco Moccia; Roberto Berra-Romani; Franco Tanzi
Journal:  World J Biol Chem       Date:  2012-07-26

Review 8.  Macrophage function in atherosclerosis: potential roles of TRP channels.

Authors:  Jean-Yves K Tano; Robert H Lee; Guillermo Vazquez
Journal:  Channels (Austin)       Date:  2012 May-Jun       Impact factor: 2.581

9.  Pharmacological evidence for a role of the transient receptor potential canonical 3 (TRPC3) channel in endoplasmic reticulum stress-induced apoptosis of human coronary artery endothelial cells.

Authors:  Prince T Ampem; Kathryn Smedlund; Guillermo Vazquez
Journal:  Vascul Pharmacol       Date:  2015-07-26       Impact factor: 5.773

10.  Inhibition of TRPC1/TRPC3 by PKG contributes to NO-mediated vasorelaxation.

Authors:  Jie Chen; Randy F Crossland; Muzamil M Z Noorani; Sean P Marrelli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.